LeMaitre Vascular Quarterly Income Statement
NASDAQ: LMATHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LeMaitre Vascular revenue and earnings
In the quarter ended Jun 30, 2026, LeMaitre Vascular generated $70.4 million in revenue, up 9.6% from the same quarter a year earlier. Net income was $17.1 million (+23.7% year over year), for a net margin of 24.2% versus a median of 23.6% in the prior 5 quarters. Gross margin was 72.1% (up from 70.0%) and operating margin 29.0%.
Diluted earnings per share came in at $0.74, up from $0.60.
Summary generated from market data by MetaCap's automated system. Methodology
LeMaitre Vascular income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 70.38M | 66.55M | 64.45M | 61.05M | 64.23M | 59.87M | 55.72M | 54.82M | 55.85M | 53.48M | 48.88M | 47.41M |
| Revenue growth (YoY) | +9.57% | +11.16% | +15.68% | +11.36% | +15.01% | +11.95% | +13.98% | +15.63% | +11.44% | +13.60% | +19.36% | +21.48% |
| Cost of Revenue | 19.62M | 18.16M | 18.26M | 15.09M | 19.26M | 18.45M | 17.13M | 17.64M | 17.38M | 16.81M | 15.62M | 16.60M |
| Gross Profit | 50.76M | 48.40M | 46.19M | 45.95M | 44.97M | 41.42M | 38.59M | 37.18M | 38.47M | 36.66M | 33.27M | 30.82M |
| Operating Expenses | 30.36M | 30.62M | 27.36M | 25.64M | 28.83M | 28.79M | 25.74M | 24.03M | 24.09M | 24.79M | 23.06M | 21.64M |
| Research & Development | 4.85M | 4.06M | 3.53M | 2.97M | 3.54M | 4.09M | 3.62M | 3.66M | 4.28M | 4.09M | 4.35M | 4.22M |
| Selling, General & Admin | 25.52M | 26.56M | 23.82M | 22.67M | 25.29M | 24.70M | 22.12M | 20.37M | 19.80M | 20.70M | 18.71M | 17.41M |
| Operating Income | 20.40M | 17.77M | 18.83M | 20.31M | 16.14M | 12.63M | 12.85M | 13.15M | 14.38M | 11.87M | 10.21M | 9.18M |
| Interest Expense | 1.30M | 1.30M | 1.30M | 1.30M | 1.30M | 1.29M | 205.00K | 0 | 0 | 0 | — | — |
| Other Income (Expense) | -294.00K | -127.00K | -581.00K | -306.00K | 247.00K | 2.00K | -238.00K | 202.00K | -11.00K | -78.00K | — | — |
| Pretax Income | 22.19M | 19.67M | 20.30M | 22.57M | 18.07M | 14.24M | 14.02M | 14.55M | 15.51M | 12.80M | 11.31M | 9.83M |
| Income Tax | 5.14M | 3.99M | 4.72M | 5.21M | 4.29M | 3.23M | 2.84M | 3.41M | 3.68M | 2.91M | 2.85M | 2.32M |
| Net Income | 17.05M | 15.68M | 15.58M | 17.36M | 13.78M | 11.01M | 11.18M | 11.14M | 11.83M | 9.89M | 8.46M | 7.50M |
| Net Income growth (YoY) | +23.74% | +42.39% | +39.32% | +55.84% | +16.51% | +11.37% | +32.12% | +48.51% | +46.04% | +63.69% | +50.44% | +37.50% |
| EPS (Basic) | 0.75 | 0.69 | 0.68 | 0.77 | 0.61 | 0.49 | 0.49 | 0.50 | 0.53 | 0.44 | 0.38 | 0.34 |
| EPS (Diluted) | 0.74 | 0.68 | 0.69 | 0.75 | 0.60 | 0.48 | 0.48 | 0.49 | 0.52 | 0.44 | 0.38 | 0.33 |
| Shares Outstanding (Basic) | 22.86M | 22.80M | — | 22.66M | 22.61M | 22.57M | — | 22.48M | 22.46M | 22.36M | — | 22.26M |
| Shares Outstanding (Diluted) | 24.53M | 23.03M | — | 24.39M | 22.89M | 22.90M | — | 22.84M | 22.73M | 22.57M | — | 22.48M |
| EBITDA | 23.06M | 20.40M | 21.44M | 22.93M | 18.79M | 15.18M | 15.27M | 15.57M | 16.76M | 14.26M | 12.65M | 11.57M |
| Gross Margin | 72.13% | 72.72% | 71.66% | 75.28% | 70.02% | 69.18% | 69.26% | 67.82% | 68.88% | 68.56% | 68.05% | 65.00% |
| Operating Margin | 28.98% | 26.71% | 29.22% | 33.27% | 25.13% | 21.09% | 23.07% | 23.98% | 25.75% | 22.20% | 20.88% | 19.36% |
| Net Margin | 24.22% | 23.56% | 24.18% | 28.44% | 21.45% | 18.39% | 20.07% | 20.32% | 21.17% | 18.49% | 17.32% | 15.82% |
This table shows 12 quarterly periods of LeMaitre Vascular's income statement, from Q2 2026 back to Q3 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow LMAT's reporting calendar. What is a income statement?